BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 24354597)

  • 21. [THE DEFEAT OF BONE TISSUE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASES].
    Gabrusskaya TV
    Eksp Klin Gastroenterol; 2016; (2):70-8. PubMed ID: 27301121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
    Vestergaard P
    Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
    Boubaker J; Feki M; Hsairi M; Fekih M; Kaabachi N; Filali A; Mebazaa A
    Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 25 (OH) vitamin D level in Crohn's disease: association with sun exposure & disease activity.
    Joseph AJ; George B; Pulimood AB; Seshadri MS; Chacko A
    Indian J Med Res; 2009 Aug; 130(2):133-7. PubMed ID: 19797809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
    Firouzi F; Rashidi M; Hashemi S; Kangavari M; Bahari A; Daryani NE; Emam MM; Naderi N; Shalmani HM; Farnood A; Zali M
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.
    Bastos CM; Araújo IM; Nogueira-Barbosa MH; Salmon CEG; de Paula FJA; Troncon LEA
    Osteoporos Int; 2017 Jul; 28(7):2167-2176. PubMed ID: 28405731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered bone metabolism in inflammatory bowel disease.
    Bischoff SC; Herrmann A; Göke M; Manns MP; von zur Mühlen A; Brabant G
    Am J Gastroenterol; 1997 Jul; 92(7):1157-63. PubMed ID: 9219790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density.
    Klaus J; Reinshagen M; Adler G; Boehm B; von Tirpitz C
    BMC Gastroenterol; 2008 Oct; 8():48. PubMed ID: 18947388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
    Koutroubakis IE; Zavos C; Damilakis J; Papadakis G; Neratzoulakis J; Karkavitsas N; Kouroumalis EA
    J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary calcium intake in patients with inflammatory bowel disease.
    Vernia P; Loizos P; Di Giuseppantonio I; Amore B; Chiappini A; Cannizzaro S
    J Crohns Colitis; 2014 Apr; 8(4):312-7. PubMed ID: 24090907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases.
    Ezzat Y; Hamdy K
    Int J Rheum Dis; 2010 Aug; 13(3):259-65. PubMed ID: 20704624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone mineral density in inflammatory bowel diseases in children].
    Szumera M; Landowski P; Kamińska B; Góra-Gebka M; Popadiuk S; Renke J
    Med Wieku Rozwoj; 2006; 10(2):445-51. PubMed ID: 16825715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD Patients.
    López-Muñoz P; Beltrán B; Sáez-González E; Alba A; Nos P; Iborra M
    Nutrients; 2019 May; 11(5):. PubMed ID: 31083541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updated bone mineral density status in Saudi patients with inflammatory bowel disease.
    Ewid M; Al Mutiri N; Al Omar K; Shamsan AN; Rathore AA; Saquib N; Salaas A; Al Sarraj O; Nasri Y; Attal A; Tawfiq A; Sherif H
    World J Gastroenterol; 2020 Sep; 26(35):5343-5353. PubMed ID: 32994692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease.
    Kuwabara A; Tanaka K; Tsugawa N; Nakase H; Tsuji H; Shide K; Kamao M; Chiba T; Inagaki N; Okano T; Kido S
    Osteoporos Int; 2009 Jun; 20(6):935-42. PubMed ID: 18825300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients.
    Abraham BP; Prasad P; Malaty HM
    Dig Dis Sci; 2014 Aug; 59(8):1878-84. PubMed ID: 24619280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of osteopenia in inflammatory bowel disease.
    Dinca M; Fries W; Luisetto G; Peccolo F; Bottega F; Leone L; Naccarato R; Martin A
    Am J Gastroenterol; 1999 May; 94(5):1292-7. PubMed ID: 10235209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 6, osteoprotegerin, sRANKL and bone metabolism in inflammatory bowel diseases.
    Krela-Kaźmierczak I; Szymczak-Tomczak A; Łykowska-Szuber L; Wysocka E; Michalak M; Stawczyk-Eder K; Waszak K; Linke K; Eder P
    Adv Clin Exp Med; 2018 Apr; 27(4):449-453. PubMed ID: 29558031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.